Loading clinical trials...
Loading clinical trials...
Multicenter, open-label, dose-escalation Phase I/Ib clinical study to evaluate the safety and tolerability, the MTD/RP2D, pharmacokinetics (PK), pharmacodynamics (PD), and antitumor activity of EOS100...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
iTeos Therapeutics
Collaborators
NCT06144671 · Solid Tumor, Adult
NCT03594422 · Gastrointestinal Stromal Tumor (GIST), Solid Tumor, Adult
NCT05223608 · Solid Tumor, Adult
NCT06625775 · Solid Tumor, Adult, Metastatic Breast Cancer, and more
NCT05888532 · Prostate Cancer, Renal Cancer, and more
Karmanos Cancer Institute
Michigan Center, Michigan
John Theurer Cancer Center, Hackensack University Medical Center
Hackensack, New Jersey
University of Texas Health Science Center at San Antonio
San Antonio, Texas
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions